Addex Therapeutics Ltd

ADXN | NASDAQ

Price Alert Chart Builder DCF Calculator

$3.53

+$0.13 (+3.98%)

At close: Sep 21, 2026, 4:00 PM ET

$3.32

-$0.21 (-5.95%)

Pre-market: Sep 22, 2026, 4:31 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-6.53M	7.06M	-10.56M	-20.8M	-15.35M	-12.86M
Depreciation & Amortization	8.09K	260.12K	305.95K	323.14K	347.61K	378.75K
Stock-Based Compensation	n/a	n/a	n/a	3.68M	1.18M	1.18M
Other Working Capital	155.37K	-1.36M	-233.29K	409.77K	-665.16K	-1.82M
Other Non-Cash Items	3.93M	-11.46M	2.04M	204.13K	32.93K	972.63K
Deferred Income Tax	n/a	n/a	n/a	n/a	-150.59K	-27.72K
Change in Working Capital	524.65K	-1.23M	213.76K	157.68K	-761.57K	-1.82M
Operating Cash Flow	-2.08M	-5.37M	-7.99M	-16.44M	-14.71M	-12.18M
Capital Expenditures	n/a	-1.27K	-6.84K	-581	-31.55K	-59.41K
Cash Acquisitions	n/a	5.12M	n/a	n/a	n/a	n/a
Purchase of Investments	-273.11K	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	3.55K	1.24K	n/a
Other Investing Acitivies	-376.98K	-473.27K	n/a	n/a	n/a	n/a
Investing Cash Flow	-650.08K	4.65M	-6.84K	2.97K	-30.31K	-59.41K
Debt Repayment	-7.31K	-73.69K	-281.79K	-288.08K	-309.62K	-367.41K
Common Stock Repurchased	n/a	-25.78K	-48.05K	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	328	-54	-11.24K	1.71M	2.75M	-306.2K
Financial Cash Flow	1.13M	104.92K	5.26M	3.1M	16.4M	46.4K
Net Cash Flow	-1.28M	-523.74K	-3.09M	-13.53M	1.79M	-12.84M
Free Cash Flow	-2.08M	-5.37M	-8M	-16.44M	-14.74M	-12.24M
Adj. Free Cash Flow	-2.08M	-5.37M	-8M	-20.12M	-15.92M	-13.42M
Maintenance CapEx	n/a	-1.27K	n/a	-581	-31.55K	n/a
Growth CapEx	n/a	n/a	-6.84K	n/a	n/a	-59.41K
Owner Earnings	-2.08M	-5.37M	-7.99M	-16.44M	-14.74M	-12.18M